tiprankstipranks

David E. Lazar Insider Profile

4 Followers
David E. Lazar, CEO, Director at Titan Pharmaceuticals, holds 100.00K shares in OpGen (Ticker: OPGN), holds 25.00K shares in Minim, Inc. (Ticker: MINM), holds 100.00K shares in Titan Pharmaceuticals (Ticker: TTNP).
tipranks
David E. Lazar

David E. Lazar
Titan Pharmaceuticals (TTNP)
CEO, Director

Ranked #67,862 out of 98,564 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-15.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$853K
83.08%
10.90%
6.02%
A breakdown of David E. Lazar's holdings

Insider Roles

Titan Pharmaceuticals
(TTNP)
CEO, Director
Minim, Inc.
(MINM)
Director, Ten Percent Owner
OpGen
(OPGN)
CEO, Director, Ten Percent Owner
Roles that David E. Lazar holds in companies

Most Profitable Insider Trade

Stock:
Titan Pharmaceuticals
(TTNP)
Rating:Informative Sell
Date:Jun 23, 2023 - Today
Return:+43.60%
The most profitable trade made by David E. Lazar

David E. Lazar's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Titan Pharmaceuticals
Jul 31, 2023
CEO, Director
Uninformative Buy
$709.00K
Minim, Inc.
Jan 24, 2024
Director, Ten Percent Owner
Uninformative Buy
$93.00K
OpGen
Apr 12, 2024
CEO, Director, Ten Percent Owner
Uninformative Buy
$51.40K
List of latest transactions for each holding click on a transaction to see David E. Lazar's performance on stock

David E. Lazar insider profile FAQ

What is the percentage of profitable transactions made by David E. Lazar?
The percentage of profitable transactions made by David E. Lazar is 33%.
    What is the average return per transaction made by David E. Lazar?
    The average return per transaction made by David E. Lazar is -15.20%.
      What stocks does David E. Lazar hold?
      David E. Lazar holds: TTNP, MINM, OPGN stocks.
        What was David E. Lazar’s latest transaction?
        David E. Lazar latest transaction was an Uninformative Buy of ―.
          What was David E. Lazar's most profitable transaction?
          David E. Lazar’s most profitable transaction was an Informative Sell of TTNP stock on June 23, 2023. The return on the trade was 43.60%.
            What is David E. Lazar's role in Titan Pharmaceuticals?
            David E. Lazar's role in Titan Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.